Citrucel Claim That Metamucil Causes Excess Gas Expelled After 20 Years
This article was originally published in The Rose Sheet
GlaxoSmithKline will discontinue claim P&G's Metamucil product causes excess gas and it Citrucel doesn't after P&G presented evidence that met NAD's standard for reopening a review. The industry self-regulation organization found GSK could no longer support its claim.
You may also be interested in...
To understand how Pepto-Bismol Ultra could be considered twice as strong as original as stated on packaging, consumers would need to "carefully review the Drug Facts on the back of both" products and "recognize that the active ingredient in both products is 525 mg of bismuth subsalicylate" but Ultra's dose is half original's.
Marketers now can petition NAD to reopen cases if they have new studies or other data supporting ad claims that were shot down by the watchdog group previously, though the bar for re-review is high, says NAD Director Laura Brett.
The private National Advertising Division is allowing marketers to petition to reopen closed cases if they have new studies or other data supporting ad claims, though the bar for re-review is high, says NAD Director Laura Brett.